Filter
1720
Filtered Results: 1720
Text search:
U.S.
Pharmacist
Featured
Recommendations
137
New Publications
446
Language
Document type
No document type
903
Studies & Reports
359
Guidelines
221
Manuals
79
Strategic & Response Plan
62
Fact sheets
31
Training Material
26
Situation Updates
15
Resource Platforms
12
Brochures
6
Infographics
6
Countries / Regions
Global
74
India
74
Kenya
59
Ethiopia
52
South Africa
45
Nigeria
39
Liberia
37
Uganda
36
Sierra Leone
35
Western and Central Europe
31
Rwanda
28
Africa
26
Ghana
24
Bangladesh
22
Nepal
21
Zambia
21
Tanzania
20
Namibia
19
Ukraine
18
Syria
18
Malawi
17
Latin America and the Carribbean
15
Myanmar / Burma
15
Lesotho
14
Eastern Europe
14
Zimbabwe
13
West and Central Africa
13
Philippines
12
Asia
12
Indonesia
12
Cambodia
11
South–East Asia Region
11
Botswana
11
Germany
10
East and Southern Africa
10
Congo, Democratic Republic of
9
Cameroon
8
Guinea
8
Eswatini/ Swaziland
8
Thailand
7
Haiti
7
Venezuela
7
Russia
7
South Sudan
7
Burkina Faso
6
Mozambique
6
Vietnam
6
Chile
5
Laos
5
Senegal
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Brazil
5
Pakistan
5
Benin
4
Albania
3
Afghanistan
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Papua New Guinea
3
Peru
2
Lithuania
2
Western Pacific Region
2
Jamaica
2
Bolivia
2
Argentina
2
Lebanon
2
Moldova
2
Sri Lanka
2
Sudan
2
Georgia
2
Central African Republic
2
Mali
2
Iraq
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Switzerland
1
Colombia
1
El Salvador
1
Turkey
1
China
1
Canada
1
Fiji
1
Estonia
1
Kyrgyzstan
1
Niger
1
Burundi
1
Mongolia
1
Qatar
1
Bulgaria
1
Hungary
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Portugal
1
Spain
1
Southern Africa
1
Egypt
1
Romania
1
Slovakia
1
Poland
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
676
Clinical Guidelines
120
Public Health
100
Key Resources
53
Women & Child Health
50
Pharmacy & Technologies
25
Capacity Building
22
Annual Report MEDBOX
2
Toolboxes
AMR
157
COVID-19
149
Pharmacy
119
HIV
114
Mental Health
109
TB
91
NCDs
49
Caregiver
48
Rapid Response
42
Ebola
37
Planetary Health
34
NTDs
34
Conflict
30
Global Health Education
29
Health Financing Toolbox
21
Refugee
17
Disability
16
Specific Hazards
8
Natural Hazards
6
Zika
5
Polio
5
Social Ethics
4
Cholera
3
Health Financing
1
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova.
These include:
Organized crime and illicit trafficking (including trafficking in persons, drugs, arms, illicit toba...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
This publication articulates the WHO Botswana Country Office’s focus and investment needs for the biennium 2022–2023, building on achievements, networks, and partnerships fostered in 2020-2021.
As the leading health authority within the United Nations system in Botswana, the WHO Country Offi...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
